Your browser doesn't support javascript.
loading
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.
Locke, Frederick L; Ghobadi, Armin; Jacobson, Caron A; Miklos, David B; Lekakis, Lazaros J; Oluwole, Olalekan O; Lin, Yi; Braunschweig, Ira; Hill, Brian T; Timmerman, John M; Deol, Abhinav; Reagan, Patrick M; Stiff, Patrick; Flinn, Ian W; Farooq, Umar; Goy, Andre; McSweeney, Peter A; Munoz, Javier; Siddiqi, Tanya; Chavez, Julio C; Herrera, Alex F; Bartlett, Nancy L; Wiezorek, Jeffrey S; Navale, Lynn; Xue, Allen; Jiang, Yizhou; Bot, Adrian; Rossi, John M; Kim, Jenny J; Go, William Y; Neelapu, Sattva S.
Afiliación
  • Locke FL; Moffitt Cancer Center, Tampa, FL, USA. Electronic address: frederick.locke@moffitt.org.
  • Ghobadi A; Washington University School of Medicine, St Louis, MO, USA.
  • Jacobson CA; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Miklos DB; Stanford University School of Medicine, Stanford, CA, USA.
  • Lekakis LJ; University of Miami Health System, Sylvester Comprehensive Cancer Center, Miami, FL, USA.
  • Oluwole OO; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Lin Y; Mayo Clinic, Rochester, MN, USA.
  • Braunschweig I; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Hill BT; Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Timmerman JM; UCLA David Geffen School of Medicine, Los Angeles, CA, USA.
  • Deol A; Karmanos Cancer Center, Wayne State University, Detroit, MI, USA.
  • Reagan PM; University of Rochester Medical Center, Rochester, NY, USA.
  • Stiff P; Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.
  • Flinn IW; Sarah Cannon Research Institute, Nashville, TN, USA.
  • Farooq U; University of Iowa, Iowa City, IA, USA.
  • Goy A; John Theurer Cancer Center, Hackensack, NJ, USA.
  • McSweeney PA; Colorado Blood Cancer Institute, Denver, CO, USA.
  • Munoz J; Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
  • Siddiqi T; City of Hope National Medical Center, Duarte, CA, USA.
  • Chavez JC; Moffitt Cancer Center, Tampa, FL, USA.
  • Herrera AF; City of Hope National Medical Center, Duarte, CA, USA.
  • Bartlett NL; Washington University School of Medicine, St Louis, MO, USA.
  • Wiezorek JS; Kite, Santa Monica, CA, USA.
  • Navale L; Kite, Santa Monica, CA, USA.
  • Xue A; Kite, Santa Monica, CA, USA.
  • Jiang Y; Kite, Santa Monica, CA, USA.
  • Bot A; Kite, Santa Monica, CA, USA.
  • Rossi JM; Kite, Santa Monica, CA, USA.
  • Kim JJ; Kite, Santa Monica, CA, USA.
  • Go WY; Kite, Santa Monica, CA, USA.
  • Neelapu SS; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lancet Oncol ; 20(1): 31-42, 2019 01.
Article en En | MEDLINE | ID: mdl-30518502
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Linfoma de Células B Grandes Difuso / Antígenos CD19 Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Linfoma de Células B Grandes Difuso / Antígenos CD19 Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article